Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2025-08-05 00:00:00 ET · period of report 2025-08-01 · accession 0000950170-25-102537 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-08-05 | 2025-08-01 | OBIO | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10% | P - Purchase | $2.75 | +700.0K | 5.29M | +15% | +$1.93M |
| DI | 2025-08-05 | 2025-08-01 | OBIO | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10% | P - Purchase | $2.75 | +1.50M | 1.50M | New | +$4.12M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-01 | P | A | 700,000 | $2.75 | 5,292,556 | I See Footnote | — | — | (F1) Represents the purchase price for each share of Common Stock purchased by the Reporting Person in the Issuer's registered public offering that closed on August 1, 2025. (F2) The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman ("Mr. Edelman") serves as the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of their indirect pecuniary interest therein, and this report shall not be deemed an admission that the Advisor or Mr. Edelman are beneficial owner of such securities for purposes of Section 16 or for any other purposes. |
| 2 | Derivative | Pre-funded Warrants (right to buy) | 2025-08-01 | P | A | 1,500,000 | $2.75 | 1,500,000 | I See footnote | $0.00 · — to — | 1,500,000 Common Stock | (F4) Represents the purchase price for each pre-funded warrant purchased by the Reporting Person in the Issuer's registered public offering that closed on August 1, 2025. (F2) The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman ("Mr. Edelman") serves as the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of their indirect pecuniary interest therein, and this report shall not be deemed an admission that the Advisor or Mr. Edelman are beneficial owner of such securities for purposes of Section 16 or for any other purposes. (F3) The pre-funded warrants are immediately exercisable and will expire on the date they are exercised in full, subject to the Beneficial Ownership Limitation. |